CTOs on the Move

Nathan Littauer Hospital

www.nlh.org

 
Nathan Littauer Hospital and Nursing Home is a full-service, 74 bed acute care hospital with an 84 bed skilled nursing home. Littauer provides the finest in state-of-the-art technology and a caring, dedicated staff of health care professionals. Over the years, the hospital has expanded its services in order offer health care that is comprehensive, accessible, and relevant to the needs of the communities we serve. The Littauer medical staff brings amazing technical expertise and competence to the residents of Fulton County and the surrounding communities. At Nathan Littauer Hospital and Nursing Home, we`re people caring for people.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nlh.org
  • 99 East State Street
    Gloversville, NY USA 12078
  • Phone: 518.725.8621

Executives

Name Title Contact Details

Similar Companies

Ambry Genetics

Ambry Genetics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Western Berks Ambulance Association

Western Berks Ambulance Association is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intelligent InSites

Intelligent InSites, Inc. is a leading provider of automation solutions that transform healthcare.

Community Interface Services

Community Interface Services is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.